Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-10-16
2007-10-16
Meller, Michael (Department: 1655)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
10920803
ABSTRACT:
The present invention is directed to sustained-release pharmaceutical formulations of therapeutic proteins containing carboxymethyl ether cellulose polymer and methods of manufacture and use thereof.
REFERENCES:
patent: 6818613 (2004-11-01), Sharma et al.
patent: WO83/01198 (1983-04-01), None
patent: WO97/07788 (1997-03-01), None
patent: WO97/28828 (1997-08-01), None
patent: WO 00/13710 (2000-03-01), None
patent: WO 00/47234 (2000-08-01), None
patent: WO 00/61169 (2000-10-01), None
Troxel et al., Journal of Animal Science, vol. 51, No. 3, 1980, pp. 652-659.
Begum Selima
Cheung Wing K.
Jin Renzhe
Kelley Marian
Menon-Rudolph Sunitha
Meller Michael
Ortho-McNeil Pharmaceutical , Inc.
LandOfFree
Aqueous sustained-release formulations of proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aqueous sustained-release formulations of proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aqueous sustained-release formulations of proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3900295